App
Moneycontrol App Android App iOS App iPad App Android Tab Blackberry Windows App Windows Tab
Subscription
Specials
Stocks
Feedback
Log In
Sign Up
Moneycontrol
Get App
Select Language
Subscription
Specials
SENSEX NIFTY
you are here:

Markets

Live TV
NIFTY 50
11201.80
-431.50 (-3.71%)
SENSEX
38297.29
-1448.37 (-3.64%)

Marksans Pharma Ltd.

BSE: 524404 | NSE: MARKSANS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE750C01026 | SECTOR: Pharmaceuticals

Success
Alert
Please select a Day.
Info
Moneycontrol Pro Thomson Reuters report
| BSE 17.05 -1.25 (-6.83%) | |

BSE Live

Feb 28, 16:00
17.05 -1.25 (-6.83%)
Volume
AVERAGE VOLUME
5-Day
112,192
10-Day
142,044
30-Day
221,607
102,376

  • Prev. Close

    18.30

  • Open Price

    18.00

16.85

Today’s L/H

18.00
11.45

52 Wk L/H

28.10
14.65

L/U Price Band

21.95

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

  •  VWAP

    17.27
     Beta
    1.34

  • Market Depth (28 Feb 2020)

    BUYSELL
    QTY PRICE PRICE QTY
    2954 16.85 16.95 802
    1633 16.80 17.00 22204
    51 16.75 17.20 1100
    1 16.65 17.40 30
    695 16.50 17.50 300
    0 Total Total 0
     Market Depth
    BUY 0
    SELL 0
    0%
    0%

NSE Live

Feb 28, 15:54
17.00 -1.35 (-7.36%)
Volume
AVERAGE VOLUME
5-Day
765,824
10-Day
964,721
30-Day
1,962,155
963,037

  • Prev. Close

    18.35

  • Open Price

    17.85

16.85

Today’s L/H

17.85
11.40

52 Wk L/H

28.10
14.70

L/U Price Band

22.00

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    17.00 (13950)

  •  VWAP

    17.28
     Beta
    1.39
  • DELIVERY AVERAGES
    3-Day
    49.05%
    5-Day
    53.57%
    8-Day
    50.79%
    Deliverables
    49.05%
  • SMA
    30
    19.45
    50
    18.80
    150
    16.13
    200
    17.34
    SMA
    19.45

Charts

  • Open : -
  • High : -
  • Low -
  • Close: -
  • Volume -

TECHNICAL ANALYSIS

TECHNICAL RATING
Very Bearish
Moving Averages Bearish
Technical Indicators Bearish
Moving Averages Crossovers Neutral
See Detail
Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 18.68 19.02 19.38 18.32 17.98 17.62 17.28
Fibonacci 18.58 18.75 19.02 18.32 18.05 17.88 17.62
Camarilla 18.41 18.48 18.54 18.32 18.29 18.22 18.16

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

SIMPLE MOVING AVERAGES
Days NSE
5 18.47
10 19.06
20 19.46
50 18.80
100 16.68
200 17.34
Get Historical Prices
Pivot levels

Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 21.03 21.97 23.18 19.82 18.88 17.67 16.73
Fibonacci 20.64 21.15 21.97 19.82 19.00 18.49 17.67
Camarilla 20.30 20.49 20.69 19.82 19.90 19.71 19.51

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.

Pivot levels
Type R1 R2 R3 PP S1 S2 S3
Classic 21.00 23.35 25.60 18.75 16.40 14.15 11.80
Fibonacci 20.51 21.59 23.35 18.75 16.99 15.91 14.15
Camarilla 19.07 19.49 19.92 18.75 18.23 17.81 17.38

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

SIMPLE MOVING AVERAGES
Pivot levels

Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.

Valuation

    • Market Cap (Rs Cr.)
      697.88
    • P/E
      19.32
    • Book Value (Rs)
      11.50
    • Dividend (%)
      5.00
    • Market Lot
      1
    • Industry P/E
      31.99
    • EPS (TTM)
      0.88
    • P/C
      15.6
    • Price/Book
      1.48
    • Dividend Yield.(%)
      0.29
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      49.05
      5-Day
      53.57
      8-Day
      50.79
      55.77

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

    • Market Cap (Rs Cr.)
      697.88
    • P/E
      7.91
    • Book Value (Rs)
      13.50
    • Dividend (%)
      5.00
    • Market Lot
      1
    • Industry P/E
      31.99
    • EPS (TTM)
      2.15
    • P/C
      6.31
    • Price/Book
      1.26
    • Dividend Yield.(%)
      0.29
    • Face Value (RS)
      1.00
    • Deliverables (%)
      DELIVERY AVERAGES (%)
      3-Day
      49.05
      5-Day
      53.57
      8-Day
      50.79
      55.77

* Note - P.E (TTM) is displayed only when latest 4 quarter results are positive.

Forum

Community Sentiments

  • 100% BUY
  • 0% SELL
  • 0% HOLD
100%
of moneycontrol users recommend buying Marksans Pharma

What's your call on Marksans Pharma today?

Read 4 investor views

BUY SELL HOLD
POST

Action in Marksans Pharma Ltd.

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 19.55 today.

    Feb 19

  • Technicals

    Marksans Pharma closes below 30-Day Moving Average of 19.43 today.

    Feb 17

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 18.60 today.

    Feb 05

  • Technicals

    Marksans Pharma closes above 200-Day Moving Average of 17.71 today.

    Feb 04

  • Technicals

    Marksans Pharma closes below 200-Day Moving Average of 17.75 today.

    Feb 03

  • Technicals

    Marksans Pharma closes above 200-Day Moving Average of 18.20 today.

    Jan 13

  • Technicals

    Marksans Pharma closes above 200-Day Moving Average of 18.45 today.

    Jan 03

  • Technicals

    Marksans Pharma closes above 150-Day Moving Average of 16.66 today.

    Dec 31

  • Technicals

    Marksans Pharma closes above 150-Day Moving Average of 16.93 today.

    Dec 17

  • Technicals

    Marksans Pharma closes above 30-Day,50-Day Moving Average today.

    Dec 16

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.24 today.

    Dec 13

  • Technicals

    Marksans Pharma closes below 30-Day Moving Average of 14.71 today.

    Nov 28

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.37 today.

    Nov 18

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 14.04 today.

    Oct 28

  • Technicals

    Marksans Pharma closes above 50-Day Moving Average of 14.57 today.

    Oct 21

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 14.12 today.

    Oct 17

  • AGM/EGM

    Marksans Pharma AGM on Sep 26, 2019, Announcement date: Aug 28, 2019

    Sep 25, 11:00

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 15.23 today.

    Sep 10

  • Technicals

    Marksans Pharma closes above 30-Day Moving Average of 15.23 today.

    Sep 09

  • Only Buyers

    Only Buyers in Marksans Pharma on BSE

    Jul 31, 14:45

News & Videos

Marksans Pharma Consolidated December 2019 Net Sales at Rs 287.65 crore, up 15.82% Y-o-Y

Marksans Pharma Consolidated December 2019 Net Sales at Rs 287.65 crore, up 15.82% Y-o-Y

Business | Earnings | Management Interviews
View More

News across the web

Data not available

Announcements

View More

Pre-Opening Session Prices9:00 am - 9:15 am

BSE

Feb 28, 09:15
18.00 -0.30 (-1.64%)
High 18.00
Low 0.00
Prev. Close 18.30

NSE

Feb 28, 09:15
17.85 -0.50 (-2.72%)
High 18.40
Low 17.85
Prev. Close 18.35

Financials

Income Statement

  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 116.88 100.72 92.42 91.18 125.19
Other Income 0.01 7.87 2.15 9.50 0.12
PBDIT 20.27 12.79 10.27 3.37 17.35
Net Profit 12.98 11.86 5.66 5.62 11.78
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results Financial Ratios
  Dec 2019 Sep 2019 Jun 2019 Mar 2019 Dec 2018
Net Sales 287.65 256.40 245.03 247.41 248.37
Other Income 0.03 7.88 2.18 9.73 0.16
PBDIT 47.27 33.57 32.42 15.65 36.19
Net Profit 29.56 25.97 22.48 9.85 25.13
Profit & Loss Nine Months Results Half Yearly Results Quarterly Results Financial Ratios

Balance Sheet

Standalone Mar 2019 Mar 2018
Total Share Capital 50.93 50.93
Networth 480.57 438.97
Total Debt 77.33 66.31
Net Block 102.61 87.89
Investments 236.07 236.07
Total Assets 557.89 505.26

Historical Prices

On
 Current Price %Gain / Loss
Open Price 23.25 18.00
-22.58
High Price 23.45 18.00
-23.24
Low Price 23.00 16.85
-26.74
Close Price 23.10 18.30
-20.78
Volume 115,502 102,376
-11.36
On
 Current Price %Gain / Loss
Open Price 23.10 17.85
-22.73
High Price 23.70 17.85
-24.68
Low Price 23.00 16.85
-26.74
Close Price 23.05 18.35
-20.39
Volume 626,458 963,037
53.73
Click Here to view the Open, High, Low, Close, Volume and Historic data for
Index Price Change %Chg
NIFTY 50 11201.80 -431.50 -3.71
SENSEX 38297.29 -1448.37 -3.64
NIFTY BANK 29147.20 -1039.80 -3.44
NIFTY IT 15213.00 -910.80 -5.65
S&P BSE Smallcap 13709.01 -500.47 -3.52
View More
Index Price Change %Chg
FTSE (Feb 28) 6,549.16 -247.24 -3.64
DAX (Feb 28) 11,870.06 -497.40 -4.02
CAC (Feb 28) 5,299.88 -195.72 -3.56
Straits Times (Feb 28) 3,011.08 -100.62 -3.23
SGX Nifty (Feb 28) 11,112.00 -55.00 -0.49
View More

CORPORATE ACTION

Date Agenda
Feb 11, 2020 Quarterly Results
Nov 12, 2019 Quarterly Results
Aug 09, 2019 Quarterly Results
May 29, 2019 Audited Results & Final Dividend
View More
Type Dividend% Ex-Dividend date
Final 5.00 Sep 19, 2019
Final 5.00 Sep 19, 2018
Final 5.00 Sep 19, 2017
Final 12.00 Sep 22, 2016
Final 12.00 Sep 23, 2015
View More
Ratio Announcement Date Ex-Bonus
No Bonus Information is available for Marksans Pharma
View More
Old FV New FV Ex-Split
10 1 Mar 11, 2008
View More
Ratio Premium Ex-Bonus
No Rights Information is available for Marksans Pharma
View More
Date Agenda
Sep 26, 2019 -
Sep 27, 2018 -
Sep 26, 2017 -
Sep 29, 2016 Rs.0.1200 per share(12%)Dividend
Sep 29, 2015 Rs.0.1200 per share(12%)Dividend
View More

Dividend Summary

For the year ending March 2019 Marksans Pharma has declared an equity dividend of 5.00% amounting to Rs 0.05 per share. At the current share price of Rs 17.00 this results in a dividend yield of 0.29%.

The company has a good dividend track report and has consistently declared dividends for the last 5 years.

SHARE HOLDING PATTERN & MUTUAL FUND HOLDING

Share Holding Pattern in (%)

Standalone June 2019 March 2019 December 2018 September 2018
Promoters 48.25 48.25 48.25 48.25
Pledged 0 0 0 0
FII/FPI 2.66 2.72 2.62 2.98
Total DII 7.57 7.82 8.11 9.03
Fin.Insts 0.29 0.4 0.32 0.36
Insurance Co 0 0 0 0
MF 0 0 0 0
Others DIIs 7.28 7.42 7.79 8.67
Others 41.52 41.21 41.03 39.73
Total 100 100 100.01 99.99

Mutual Funds Holding

Data not available

PEERS COMPARISON

Company Name Last Price % Change 52 Wk High 52 Wk Low Market Cap Sales Qtr Net Profit Qtr
Marksans Pharma 17.05 -6.83 28.10 11.45 697.88 424.16 43.62
Sun Pharma 372.95 -3.98 484.10 350.40 89483.2 10,303.21 816.60
Divis Labs 2113.70 -2.10 2239.55 1466.95 56112.09 4,879.66 1,332.65
Dr Reddys Labs 2925.80 -4.66 3363.00 2352.00 48616.01 10,625.50 1,277.30
Torrent Pharma 2142.40 -1.47 2285.95 1453.00 36254.28 5,762.00 745.00

COMPANY OVERVIEW

Marksans Pharma Limited together with its subsidiaries operates as an integrated international pharmaceutical company. The Companys business is distribution of pharmaceutical products. It is actively engaged in research and development (R&D) and offering contract research and manufacturing services (CRAMS) to global pharmaceutical companies. The R&D capability of the Company includes dossier development service, formulation development and specified drug delivery system. The Companys domestic formulation business is the specialty division, which mainly focuses on oncology and critical care therapy. The brands of this division are MARKPARIN and EPIGROF. EPIGROF is also being supplied to hospitals and other burns and trauma care institutes. Cerebella division is the specialty division marketing drugs meant for lifestyle diseases, neuro and psychiatric therapy. The brands of this division are BAZZY, CITOFAST, GABELLA, GABELLA M, XENOTRIL, which are the main contributors of sales.

COMPANY INFORMATION

  • Registered Office

  • Registrars

  • Management

    • Name

      Designation

    • Mark Saldanha

      Chairman & Managing Director

    • Sandra Saldanha

      Whole Time Director

    • Varddhman Vikramaditya Jain

      Whole Time Director

    • Ajay S Joshi

      Independent Director

    • Abhinna Sundar Mohanty

      Independent Director

  • Listing

    Whether The Company Forms A Part Of The Following Indices -
    • Sensex

      No

    • Nifty

      No

    • Bse-100

      No

    • Bse-200

      No

    • S&P CNX 500

      No

    • CNX Midcap

      No

About Marksans Pharma Ltd.

Marksans Pharma is in the Pharmaceuticals sector.

It is listed on the BSE with a BSE Code of 524404 and the NSE with an NSE Code of MARKSANS.

Quick links

News

Corporate Action

Information

Financials

Annual Report

Peer Comparison

Related Searches

Marksans Pharma Stock Price | Marksans Pharma Stock Quote | Marksans Pharma Results | Marksans Pharma News | View All Related Searches
Sections
Desktop Version »
Follow us on
Facebook Twitter Instagram
Available On
Download from Google Play Download from App Stoer Download from Windows Phone
Disclaimer | Terms & Conditions | Privacy Policy | Cookie Policy | FAQs | Sitemap | Feedback
Network 18 Sites: News18 | Firstpost | CNBC TV18 | In.com | Cricketnext | Overdrive | Topper Learning

Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.